BlackRock Health Sciences Term Trust - Fundamentals

Feel free to try out our engine!Whenever you're ready, pick a plan!

Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Insider Tracker is here!

Try it now Watch the presentation

‌
‌

‌

Let's get started...

‌

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	TTM
REVENUE	0	5	60	-26	8	24	24	📊
Revenue Growth (1Y)	--	--	+1038.24%	-143.53%	+131.55%	+193.79%	--	📊
Revenue Growth (5Y)	--	--	--	--	--	+359.25%	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	📊
Cost of Revenue	0	0	0	0	-8	0	--	📊
Cost of Revenue Growth (1Y)	--	--	--	--	--	+100.00%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	--	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	📊
Gross Profit	0	5	6	-26	29	24	24	📊
Gross Profit Growth (1Y)	--	--	+22.14%	-505.67%	+211.18%	-16.63%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	--	+359.25%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	📊
Operating Expenses	0	5	6	-26	0	1	1	📊
Operating Expenses Growth (1Y)	--	--	+22.72%	-509.12%	+101.52%	+56.78%	--	📊
Operating Expenses Growth (5Y)	--	--	--	--	--	-88.07%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	📊
Sell General Administrative	0	5	6	0	0	0	--	📊
Research and Development	0	0	0	0	0	0	--	📊
Other Income Expenses	0	0	0	-26	0	0	--	📊
EBITDA	0	0	0	-26	20	1	1	📊
EBITDA Growth (1Y)	--	--	--	-49177.77%	+175.65%	-95.37%	--	📊
EBITDA Growth (5Y)	--	--	--	--	--	--	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	📊
Depreciation and Amortization	0	0	0	0	0	0	--	📊
Operating Income	0	0	0	2	8	1	1	📊
Operating Income Growth (1Y)	--	--	-21.67%	+2754.36%	+449.78%	-89.05%	--	📊
Operating Income Growth (5Y)	--	--	--	--	--	+1246.54%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	0	0	0	--	📊
Pre Tax Income	0	80	59	-26	20	23	23	📊
Tax Provision	0	0	0	0	0	0	--	📊
NET INCOME	0	80	59	-26	20	23	23	📊
Net Income Growth (1Y)	--	--	-25.69%	-144.78%	+175.62%	+17.17%	--	📊
Net Income Growth (5Y)	--	--	--	--	--	-70.52%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	📊
Basic EPS	1.45	11.63	0.52	-2.1	1.44	1.77	1.77	📊
Diluted EPS	1.45	11.63	0.52	-2.1	1.44	1.77	1.77	📊
Basic Average Shares	113	113	113	13	14	13	14	📊
Diluted Average Shares	113	113	113	13	14	13	14	📊

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	TTM
REVENUE	0	5	60	-26	8	24	24	📊
Revenue Growth (1Y)	--	--	+1038.24%	-143.53%	+131.55%	+193.79%	--	📊
Revenue Growth (5Y)	--	--	--	--	--	+359.25%	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	📊
Cost of Revenue	0	0	0	0	-8	0	--	📊
Cost of Revenue Growth (1Y)	--	--	--	--	--	+100.00%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	--	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	📊
Gross Profit	0	5	6	-26	29	24	24	📊
Gross Profit Growth (1Y)	--	--	+22.14%	-505.67%	+211.18%	-16.63%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	--	+359.25%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	📊
Operating Expenses	0	5	6	-26	0	1	1	📊
Operating Expenses Growth (1Y)	--	--	+22.72%	-509.12%	+101.52%	+56.78%	--	📊
Operating Expenses Growth (5Y)	--	--	--	--	--	-88.07%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	📊
Sell General Administrative	0	5	6	0	0	0	--	📊
Research and Development	0	0	0	0	0	0	--	📊
Other Income Expenses	0	0	0	-26	0	0	--	📊
EBITDA	0	0	0	-26	20	1	1	📊
EBITDA Growth (1Y)	--	--	--	-49177.77%	+175.65%	-95.37%	--	📊
EBITDA Growth (5Y)	--	--	--	--	--	--	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	📊
Depreciation and Amortization	0	0	0	0	0	0	--	📊
Operating Income	0	0	0	2	8	1	1	📊
Operating Income Growth (1Y)	--	--	-21.67%	+2754.36%	+449.78%	-89.05%	--	📊
Operating Income Growth (5Y)	--	--	--	--	--	+1246.54%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	0	0	0	--	📊
Pre Tax Income	0	80	59	-26	20	23	23	📊
Tax Provision	0	0	0	0	0	0	--	📊
NET INCOME	0	80	59	-26	20	23	23	📊
Net Income Growth (1Y)	--	--	-25.69%	-144.78%	+175.62%	+17.17%	--	📊
Net Income Growth (5Y)	--	--	--	--	--	-70.52%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	📊
Basic EPS	1.45	11.63	0.52	-2.1	1.44	1.77	1.77	📊
Diluted EPS	1.45	11.63	0.52	-2.1	1.44	1.77	1.77	📊
Basic Average Shares	113	113	113	13	14	13	14	📊
Diluted Average Shares	113	113	113	13	14	13	14	📊

BlackRock Health Sciences Term Trust - Fundamentals - Financial Statements

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	15.36%
Next Earnings	--
Market cap	218.72M (USD)
EPS (TTM)	1.77 ($)
P/E (TTM)	9.32 ($)
Last Close	16.50

Next Earnings	--
Market cap	218.72M (USD)
EPS (TTM)	1.77 ($)
P/E (TTM)	9.32 ($)
Last Close	16.50 ($)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	15.36%
Next Earnings	--
Market cap	218.72M (USD)
EPS (TTM)	1.77 ($)
P/E (TTM)	9.32 ($)
Last Close	16.50

Next Earnings	--
Market cap	218.72M (USD)
EPS (TTM)	1.77 ($)
P/E (TTM)	9.32 ($)
Last Close	16.50 ($)